Compare AdaptHealth Corp (AHCO) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Lockheed Martin Corporation — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Lockheed Martin Corporation trades at $530.15 (market cap $123.44B). The key difference: Lockheed Martin Corporation is far larger — about 89.4× AdaptHealth Corp's market cap, and Lockheed Martin Corporation pays a 2.58% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | LMT | |
|---|---|---|
Market Cap | $1.38B | $123.44B |
Sector | Health | Industrials |
52-Week High | $13.38 | $676.70 |
52-Week Low | $8.68 | $410.74 |
Enterprise Value | $3.33B | $142.24B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Lockheed Martin (LMT) trades at $535.38, down 1.89% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $627.50. Recent financials show revenue growth to $75.05B in 2025, though net income margin declined to 6.38%. The company announced a $3.45B acquisition of Ultra Maritime to expand naval defense capabilities, and a dividend of $3.45 is scheduled for payment in June 2026.
LMT offers stability through government contracts and dividend growth, but faces risks from execution on recent acquisitions and margin pressure. Analyst sentiment is positive with 57% buy ratings, yet recent earnings misses and rising debt levels warrant caution. The stock presents a long-term opportunity in defense, balanced by near-term operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
